Angelini Ventures — Full Portfolio

Genialis is a precision oncology company that applies data analysis to help drug developers understand mechanisms of action, resistance, and patient stratification for cancer therapies.

AI & Machine LearningBiotechDigital HealthMedical DevicesBoston, US

Miha Štajdohar(Executive Officer, Director)inRafael Rosengarten(Chief Executive Officer and Co-founder)inLuka Ausec(Executive Officer)inHamzeh Abdul-Hadi(Director)Tjasa Krisper Kutin(Executive Officer)

BoardIta Lu(Director)in

Co-investorsTaiwania CapitalDebiopharm Innovation FundFirst Star VenturesScaleX Venturesredalpine

Nuevocor is a biotechnology company developing gene therapy treatments for cardiovascular and metabolic diseases.

BiotechDigital HealthHealthtechMedical DevicesSingapore, SG

Brian Burke(Co-Founder and Advisor)inMark Kay(Co-Founder and Advisor)Colin Stewart(Co-Founder and Advisor)Yann Chong Tan(Co-Founder and Advisor)inMonica Shah(Chief Medical Officer)inAl Gianchetti(Chief Executive Officer)in

Co-investorsKurma PartnersBoehringer Ingelheim Venture FundClavystBioHighlight CapitalSEEDS Capital

Adcytherix is a clinical-stage biopharmaceutical company developing next-generation antibody-drug conjugates (ADCs) that use approved cancer drugs as payloads combined with optimized conjugation design to overcome resistance in precision oncology.

BiotechHealthtechMedical Devices

Jack Elands(Founder & CEO)inXavier Preville(Co-founder, VP & Head of Research & Preclinical Development)inJan H.M. Schellens(Chief Medical Officer)inThierry Menguy(VP & Head of CMC Operations)inJaime Arango(Chief Financial Officer)inPaul Jackson(Chief Operating Officer)in

Co-investorsaMoonRA CapitalBpifranceAndera PartnersKurma PartnersPontifax Venture Capital+1 more

AgelessRx offers prescription weight management medications delivered through a telehealth platform, including GLP-1 medications (semaglutide, tirzepatide), FDA-approved weight loss drugs (Wegovy, Zepbound), and supportive treatments like metformin and vitamin injections for adults seeking medically-supervised weight loss.

BiotechDigital HealthDirect to ConsumerHealthtechLongevityAnn Arbor, US

Anar Isman(Co-Founder & Chief Executive Officer)Robert Michael Pejovich(Director of Finance of the Issuer)

Co-investors1/1 Capitalabrdn plcFidelity InvestmentsJanus Henderson InvestorsSanofi Ventures

Avation Medical manufactures the Vivally System, an FDA-cleared wearable device that uses transcutaneous tibial nerve stimulation to treat overactive bladder and urge urinary incontinence in at-home 30-minute sessions.

Digital HealthHealthtechMedical DevicesValencia, US

Jill Schiaparelli(Executive Officer, Director)inKevin Wasserstein(Director)

BoardThomas Shehab, MD(Director)

Co-investorsArboretum VenturesShangBay Capital LLCAvestria Ventures

Cadence develops a neuromodulation system intended to be a more effective, less invasive treatment for people living with drug-refractory epilepsy.

BiotechDigital HealthHealthtechMedical DevicesSammamish, US

Kent Leyde(Executive Officer, Director, Promoter)Warren Douglas Sheffield(Executive Officer, Director, Promoter)

Co-investorsJAZZ Venture PartnersLumira VenturesF-Prime CapitalIaso Ventures

Comind is developing non-invasive neurotechnology that measures a range of neurophysiological brain signals in a single bedside measurement.

Deep TechHealthtechMedical Devices

James Dacombe(Founder)in

Co-investorsBackedCrane Venture PartnersOctopus Ventures

Biotechnology company operating at the intersection of computational and experimental drug discovery.

Co-investorsBDC Thrive Venture Fund for Women

COUR develops antigen-specific immunotherapies that reprogram the immune system to treat the underlying causes of autoimmune and immune-mediated diseases while preserving normal immune function.

BiotechHealthtech

Co-investorsAlpha Wave GlobalLumira VenturesRoche Venture FundJDRF T1D Fund

Damona develops precision neuromedicines aimed at treating cognitive deficits associated with neurodegenerative and psychiatric disorders such as Alzheimer's disease, depression, and schizophrenia.

BiotechDeep TechDigital HealthHealthtechMedical Devices

Co-investorsLumira VenturesNoeticToronto Innovation Acceleration Partners

Elkedonia is a biotech company developing a novel antidepressant treatment that targets intracellular neuroplasticity pathways rather than synaptic mechanisms, with the goal of providing rapid, long-lasting relief for depression patients.

BiotechDigital HealthMental Health

Delphine Charvin(Founding Chief Executive Officer & Board Director)Mélanie Rouillier(VP, Chief Operations Officer & Co-Founder)Jocelyne Caboche(President of the Scientific Advisory Board & Co-Founder)

Co-investorsCARMA FUNDKurma Partners

Freya Biosciences develops innovative therapies targeting immune-mediated diseases that affect women.

BiotechFemTechHealthtech

Colleen Acosta, PhD(CEO, Co-Founder)Johan van Hylckama Vlieg, PhD(CSO, Co-Founder)

Co-investorsIndaco Venture PartnersOMX VenturesSofinnova Partners

Handspring provides virtual mental health therapy for children, teens, and young adults, with insurance coverage and rapid access to care without waitlists.

Digital HealthHealthtechMental Health

Sahil Choudhryin

Co-investors25MadisonCobalt VenturesCornucopian Capital ManagementNextView VenturesNVP CapitalRPS Ventures+3 more

HyperSpectral develops a spectral sensing and AI layer for Physical AI that interprets matter through spectral data, molecular identification, and AI architecture.

AI & Machine LearningDeep TechDefense TechHardwareAlexandria, US

Matthew Theurer(Executive Officer, Director)Lauren Stack(Executive Officer, Director)inVincent Lubsey(Executive Officer)

BoardJuan Lopez(Director)inWilliam Porteous(Director)in

Co-investorsKibo VenturesGlade Brook Capital PartnersHeal CapitalLifeX VenturesRRE VenturesZEISS Ventures

Hypervision Surgical develops an intraoperative hyperspectral imaging system that uses AI to provide real-time, contrast-free tissue characterisation during surgery.

AI & Machine LearningHealthtechMedical Devices

Co-investorsHeal CapitalHeran PartnersLifeX VenturesMeridian Health VenturesSonorcapredalpine+1 more

Laigo Bio develops targeted protein degradation therapies using its SureTACs (Surface Removal Targeting Chimeras) platform, which uses bispecific antibodies to direct cell-surface proteins toward lysosomal degradation via membrane-bound E3 ligases.

BiotechHealthtech

Co-investorsCurie CapitalKurma Partners

Nobi manufactures intelligent lamps equipped with optical sensors and artificial intelligence to detect falls and monitor health for elderly care in residential facilities and home settings.

AI & Machine LearningHealthtechIoT

Co-investors15th RockEQT Life SciencesPMV

Noctrix Health develops clinically validated wearable therapeutics for managing chronic neurological disorders, with its first product Nidra receiving FDA De Novo authorization and dedicated CMS HCPCS codes.

Digital HealthMedical DevicesWellness & FitnessPleasanton, US

Shri Raghunathan(Founder)in

Co-investorsBlue Venture FundsOrbiMedTreo Ventures, LlcZühlke VenturesBridge BankSandbox Clinical Ventures+1 more

Co-investors5AM VenturesAndera PartnersCDP Venture CapitalIndaco Venture PartnersM VenturesXGEN Venture

Nuclidium is a clinical-stage biotechnology company developing copper-based radiopharmaceuticals for cancer diagnosis and treatment, using Copper-61 for diagnostics and Copper-67 for therapeutics.

BiotechHealthtechMedical DevicesBasel, CH

Co-investorsDeepTech & Climate FondsKurma PartnersNeva Sgr.VIVES Partners

Serenis is an online mental health platform offering video sessions with vetted psychologists, psychotherapists, psychiatrists, coaches, and nutritionists, covering individual, couples, ADHD, psychiatry, sexology, and eating-disorder care.

Digital HealthMarketplacesMental Health

Co-investorsGruppo BertoldiLumen Ventures

Therini Bio is a biotechnology company developing fibrin-targeting therapeutics to treat neurological and ophthalmological diseases, leveraging scientific discoveries in neurovascular and neuroimmune mechanisms of disease.

BiotechDigital HealthHealthtechMedical DevicesSacramento, US

Katerina Akassoglou(Scientific Founder, Director of the Center for Neurovascular Brain Immunology and Professor of Neurology at UCSF and Gladstone Institutes)inKaterina Akassoglou, PhD(Scientific Founder)Leslie Schulze(Executive Officer)Tara Nickerson(Executive Officer, Director)in

BoardOlga Danilchanka(Director)Laia Crespo-Martin(Director)

Co-investorsMRL Ventures FundSanofi VenturesSV Health InvestorsMitsui Global InvestmentApollo Health VenturesDementia Discovery Fund+1 more